Claudia Mailander
Overview
Explore the profile of Claudia Mailander including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
208
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Koschel D, Mailander C, Schwab Sauerbeck I, Schreiber J
Allergy Asthma Clin Immunol
. 2020 Dec;
16(1):92.
PMID: 33292478
Background: This differential diagnosis of allergic vs non-allergic asthma is typically made on the basis of sensitization to allergens, such that absence of sensitization could result in a patient being...
2.
Kleine-Tebbe J, Mailander C
J Allergy Clin Immunol Pract
. 2019 Dec;
8(2):744-746.e3.
PMID: 31821917
No abstract available.
3.
Schreiber J, Schwab Sauerbeck I, Mailander C
Adv Ther
. 2019 Nov;
37(1):353-363.
PMID: 31741282
Introduction: Allergic asthma is a chronic inflammatory disease caused by immunoglobulin E (IgE)-mediated allergy. Omalizumab is a monoclonal anti-IgE antibody for the treatment of severe allergic asthma (SAA). Objectives: The...
4.
Kardos P, Vogelmeier C, Worth H, Buhl R, Lossi N, Mailander C, et al.
Respir Med
. 2017 Mar;
124:57-64.
PMID: 28284322
Introduction: DACCORD is an observational, non-interventional study being conducted in German primary and secondary care centres. The study aims to describe the impact of disease (including exacerbations) and treatments over...
5.
Vogelmeier C, Worth H, Buhl R, Criee C, Lossi N, Mailander C, et al.
Int J Chron Obstruct Pulmon Dis
. 2017 Feb;
12:487-494.
PMID: 28203072
Many patients with chronic obstructive pulmonary disease (COPD) receive inhaled corticosteroids (ICSs) without a clear indication, and thus, the impact of ICS withdrawal on disease control is of great interest....
6.
Watz H, Mailander C, May C, Baier M, Kirsten A
Pulm Pharmacol Ther
. 2016 Dec;
42:13-20.
PMID: 27940287
Background: Long-acting bronchodilators, including anticholinergics glycopyrronium and tiotropium, are central to symptomatic management of chronic obstructive pulmonary disease (COPD). In patients with moderate to severe COPD, glycopyrronium has demonstrated comparable...
7.
Buhl R, Criee C, Kardos P, Vogelmeier C, Lossi N, Mailander C, et al.
Int J Chron Obstruct Pulmon Dis
. 2016 Aug;
11:1639-46.
PMID: 27499620
Introduction: Randomized interventional trials generally recruit highly selected patients. In contrast, long-term, noninterventional studies can reflect standard of care of real-life populations. DACCORD (Die ambulante Versorgung mit langwirksamen Bronchodilatatoren: COPD-Register...
8.
Watz H, Mailander C, Baier M, Kirsten A
BMC Pulm Med
. 2016 Jun;
16(1):95.
PMID: 27301417
Background: Physical activity limitation is common in chronic obstructive pulmonary disease (COPD), and is associated with worse health status, and increased hospitalisation and mortality. Long-acting bronchodilators, either alone or in...
9.
Worth H, Buhl R, Criee C, Kardos P, Mailander C, Vogelmeier C
Respir Med
. 2016 Jan;
111:64-71.
PMID: 26775251
Introduction: DACCORD is an ongoing, longitudinal, non-interventional study within the German COPD National Prospective Registry. This manuscript describes the baseline characteristics of the first 5924 participants, recruited between November 2012...
10.
Stephan J, Bender J, Wolschendorf F, Hoffmann C, Roth E, Mailander C, et al.
Mol Microbiol
. 2005 Oct;
58(3):714-30.
PMID: 16238622
Mycobacteria have a unique outer membrane (OM) that is thicker than any other known biological membrane. Nutrients cross this permeability barrier by diffusion through porins. MspA is the major porin...